Immix Biopharma (IMMX) director Adams received 6,250 shares

Insider transactions reported

Helen C. Adams (director at Immix Biopharma Inc., IMMX) reported that they received 6,250 shares on May 22, 2026. After these transactions the filing shows 181,004 shares held directly.

Reporting person

Adams Helen C.

Options and other derivatives

Holdings before and after

• Common Stock: 174,754 to 181,004 direct
• Stock Option (Right to Buy): 0 to 12,500 direct

Footnotes from the filing

1. 1. The Reporting Person was granted 6,250 restricted stock units ( RSUs ) pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the 2027 Annual Meeting ) is held, subject to the Reporting Person's continued service with the Issuer.
2. 2. The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ